Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.
The ERISA Industry Committee, a group for employers with self-funded benefit plans, says Congress should make pharmacy ...
The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebatin ...
This week's healthcare newsletter looks at the prospect for prior authorization reform for prescription drugs and a major FTC ...
FTC Takes Action Against Pharmacies Inflating Insulin Prices (Washington, DC) -- The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices. The FCC says ...
A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...
The Federal Trade Commission sues pharmacy benefit managers over high insulin prices ... lower-cost insulin products from ...
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
The FTC in July issued a scathing interim report saying that Cigna/Express Scripts, CVS Health and UnitedHealth Group ...
The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback